Health & coverage · Rheumatoid arthritis
Rheumatoid arthritis is one of the friendlier autoimmune conditions in final expense underwriting — several carriers publish it at their day-one tiers. Where it gets complicated is the medicine cabinet: methotrexate, biologics like Humira or Enbrel, and infusions like Rituxan are read very differently from one carrier to the next. Here’s the honest map.
The honest landscape
On final expense, RA by itself usually isn’t the problem. Corebridge’s SimpliNow Legacy guide lists rheumatoid or psoriatic arthritis among the conditions eligible for its level plan. Transamerica’s official Immediate Solution guide charts rheumatoid arthritis at Preferred. American Amicable’s Senior Choice drug guide lists methotrexate and Rituxan prescribed for RA at its Immediate plan, with no lookback. Royal Neighbors’ Ensured Legacy grid lists arthritis — without separating rheumatoid from other types — as eligible at every class, Preferred included. And United Home Life lists RA among the conditions eligible for both its whole life and term plans.
The medicine cabinet is where answers diverge, especially on term. Mutual of Omaha’s Express reference declines moderate or severe RA treated with medications such as Humira, Enbrel, methotrexate, or Xeljanz for its Term Life Express and IUL Express, and Rituxan sits on its Living Promise not-eligible drug list. American Amicable’s Easy Term declines methotrexate or Rituxan prescribed for RA. Transamerica’s FE Express excludes current azathioprine, cyclosporine, and CellCept, whatever they’re prescribed for. And because methotrexate and Rituxan are also cancer drugs, carriers rate them by why they’re prescribed — Aetna’s drug list flags them on its Accendo plans only when the use is cancer.
Severity shows up through function questions, not the RA question. Needing help with daily activities, or relying on a wheelchair because of a chronic illness, routes to graded, guaranteed-issue, or not-eligible outcomes at most carriers we reviewed. Under 50, American Amicable’s Family Choice routes RA to its return-of-premium plan. And the honest floor never moves: guaranteed-issue whole life asks nothing. Mutual of Omaha’s runs to age 85, Corebridge’s and Americo’s to 80 — with a graded period for natural-cause death in the first two years (three at Americo) and full accidental coverage from day one.
Your realistic paths
Corebridge (level plan), Transamerica Immediate Solution (Preferred on the chart), American Amicable Senior Choice (methotrexate or Rituxan for RA at Immediate), and Royal Neighbors (arthritis at every class) all publish day-one paths.
Wheelchair use and help with daily activities route to graded or guaranteed tiers at several carriers; American Amicable’s Family Choice (ages 0–49) routes RA to its return-of-premium plan.
No health questions — any medication, any severity. Mutual of Omaha to 85, Corebridge and Americo to 80. Graded period for natural causes; accidents covered in full from day one.
What moves the needle
Several carriers publish it at their best or standard day-one tiers. Severity, disability, and specific medications are what move an application down the ladder.
Mutual of Omaha’s term and IUL Express products decline moderate or severe RA on Humira, Enbrel, methotrexate, or Xeljanz; American Amicable’s Easy Term declines methotrexate or Rituxan for RA. Final expense is far more forgiving.
Methotrexate and Rituxan double as cancer drugs. American Amicable lists them at Immediate for RA but on a cancer clock otherwise, and Aetna flags them on Accendo plans only for cancer — so tell us the reason for every prescription.
Inside the application
Where the doors are
Every carrier draws its lines differently — these documented niches are why we shop your exact situation instead of accepting the first answer. Sources labeled; guidelines change without notice.
SimpliNow Legacy lists rheumatoid or psoriatic arthritis among the conditions eligible for its level (Max) plan, ages 50–80. Based on a 2021 training guide — we confirm current rules before quoting.
Our full AIG (Corebridge) reviewRheumatoid arthritis is Preferred on the Immediate Solution single-condition chart, and the guide’s own worked example places an applicant on Humira (for Crohn’s) at Preferred. FE Express separately excludes current azathioprine, cyclosporine, and CellCept.
Our full Transamerica reviewSenior Choice lists methotrexate and Rituxan for RA at Immediate with no lookback. Family Choice (ages 0–49) routes RA to return-of-premium, and Easy Term declines those drugs when they’re prescribed for RA.
Our full American Amicable reviewThe Ensured Legacy risk grid lists arthritis at every rate class, Preferred included. It doesn’t separate rheumatoid arthritis from other types, so we confirm your medications with underwriting first.
Our full Royal Neighbors of America reviewTerm Life Express and IUL Express decline moderate or severe RA treated with Humira, Enbrel, methotrexate, or Xeljanz, and Rituxan is on Living Promise’s not-eligible drug list — we check your exact regimen before choosing a product.
Our full Mutual of Omaha reviewIts published drug list (2020 edition) flags methotrexate and Rituxan on the Accendo plans only when they’re prescribed for cancer.
Our full Aetna (Accendo) reviewStraight answers
Usually not on final expense. American Amicable’s Senior Choice lists methotrexate for RA at its Immediate plan, and Aetna’s drug list flags it on the Accendo plans only when it’s prescribed for cancer. It matters more on term: Mutual of Omaha’s Term Life Express excludes it, and American Amicable’s Easy Term declines it for RA. Always tell us why a drug is prescribed — carriers rate methotrexate very differently when it’s for cancer.
On final expense, less than you’d think: none of the final expense drug lists we reviewed names Humira or Enbrel (the lists aren’t exhaustive, so we verify), and Transamerica’s own worked example places an applicant on Humira at Preferred. Where biologics matter is term — Mutual of Omaha declines moderate or severe RA treated with Humira, Enbrel, methotrexate, or Xeljanz on its Term Life Express and IUL Express.
Sometimes. United Home Life lists RA among the conditions eligible for both its whole life and term plans, and an older multi-carrier term grid we reviewed accepted mild RA with no limitations at some carriers. Moderate or severe RA on biologics or methotrexate is where simplified term usually says no — Mutual of Omaha and American Amicable both publish those declines.
That’s the real hinge. Transamerica’s FE Express rates wheelchair confinement at Graded, Royal Neighbors routes regular wheelchair or electric-scooter use to guaranteed issue, and American Amicable’s Senior Choice and NewBridge treat a chronic-illness wheelchair as not eligible. If daily-activity questions close the doors, guaranteed-issue whole life asks nothing — ages 45–85 with Mutual of Omaha, with a graded period for natural causes and accidents covered in full from day one.
One search, every door
A few basic questions — age, state, and your honest health picture — are exactly what lets us quote you accurately across the whole panel. A decline somewhere else is the start of our search, not the end. No exam to look, no spam, no pressure.
